Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 GVK Biosciences | Contract Pharma
Breaking News, Promotions & Moves

GVK Biosciences

Manni Kantipudi has been named president, GVK Biosciences and will be based out of the corporate office in India. Mr. Manni will be responsible for operations and helping the company grow as a service provider to global pharmaceutical and biotechnology companies.

Mr. Manni Kantipudi joins the company with more than 15 years of experience in the IT industry where he held several leadership positions. Mr. Kantipudi was with Intel Corp. since 1992 and was the first director of Intel India from 2000-2003 where he was responsible for strategic and operational aspects of starting, growing and sustaining its R&D development center in Bangalore. From 2003-2004, he was chief information officer Asia responsible for all internal IT for the Greater Asia region including Japan, China, Malaysia, Singapore, Taiwan, Philippines and South Asia.

Most recently, Mr. Kantipudi was based in the U.S. as director of software and validation for Intel’s WiFi technology Centrino laptop product line where he managed a global team of engineers and was responsible for innovative product designs and bringing key Intel products to market in high volume.

G.V. Sanjay Reddy, GVK Bio’s chief executive officer, said, “With several years of strong operational and management experience in one of the largest global companies, we are confident that Mr. Manni will be a very valuable addition to GVK BIO.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters